CIK 0001819790
- Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 814717861
- Phone
- +1 949-409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- 4 Gift Director gave 6,016 shares (gift)
- 4 Option exercise Director acquired 1,333 shares (option exercise)
- 4 Open-market sale Director sold 35,000 shares at an average $26.08 ($912,961)
- 4 Option exercise Director acquired 3,350 shares (option exercise)
- 4 Option exercise Director acquired 3,350 shares (option exercise)
- 4 Option exercise Director acquired 3,350 shares (option exercise)
- 4 Option exercise Director acquired 3,350 shares (option exercise)
- 4 Option exercise Director acquired 3,350 shares (option exercise)
- 4 Option exercise Director acquired 3,350 shares (option exercise)
- 4 Option exercise Director acquired 3,350 shares (option exercise)
- 4 Open-market sale See Remarks sold 10,445 shares at $27.47 ($286,924)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Commercial Officer sold 4,766 shares at $30.60 ($145,840)
- 4 Open-market sale General Counsel sold 4,436 shares at $30.60 ($135,742)
Page 6 of 17 · 330 filings